Literature DB >> 22310680

Ironing out tau's role in parkinsonism.

Jeannette N Stankowski, Valina L Dawson, Ted M Dawson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22310680      PMCID： PMC4455923          DOI： 10.1038/nm.2668

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

1.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

Authors:  Peng Lei; Scott Ayton; David I Finkelstein; Loredana Spoerri; Giuseppe D Ciccotosto; David K Wright; Bruce X W Wong; Paul A Adlard; Robert A Cherny; Linh Q Lam; Blaine R Roberts; Irene Volitakis; Gary F Egan; Catriona A McLean; Roberto Cappai; James A Duce; Ashley I Bush
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

2.  Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

Authors:  Jonathan Wills; Jessica Jones; Thomas Haggerty; Valeriy Duka; Jeffrey N Joyce; Anita Sidhu
Journal:  Exp Neurol       Date:  2010-06-28       Impact factor: 5.330

3.  Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.

Authors:  Victoria Zhukareva; Sonali Sundarraj; David Mann; Magnus Sjogren; Kaj Blenow; Christopher M Clark; Daniel W McKeel; Alison Goate; Carol F Lippa; Jean-Paul Vonsattel; John H Growdon; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2003-01-25       Impact factor: 17.088

4.  Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

Authors:  James A Duce; Andrew Tsatsanis; Michael A Cater; Simon A James; Elysia Robb; Krutika Wikhe; Su Ling Leong; Keyla Perez; Timothy Johanssen; Mark A Greenough; Hyun-Hee Cho; Denise Galatis; Robert D Moir; Colin L Masters; Catriona McLean; Rudolph E Tanzi; Roberto Cappai; Kevin J Barnham; Giuseppe D Ciccotosto; Jack T Rogers; Ashley I Bush
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

Review 5.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 6.  The many faces of tau.

Authors:  Meaghan Morris; Sumihiro Maeda; Keith Vossel; Lennart Mucke
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

7.  Tau reduction prevents Abeta-induced defects in axonal transport.

Authors:  Keith A Vossel; Kai Zhang; Jens Brodbeck; Aaron C Daub; Punita Sharma; Steven Finkbeiner; Bianxiao Cui; Lennart Mucke
Journal:  Science       Date:  2010-09-09       Impact factor: 47.728

8.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Authors:  Yaroslau Compta; Laura Parkkinen; Sean S O'Sullivan; Jana Vandrovcova; Janice L Holton; Catherine Collins; Tammaryn Lashley; Constantinos Kallis; David R Williams; Rohan de Silva; Andrew J Lees; Tamas Revesz
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

9.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

Authors:  H N Dawson; A Ferreira; M V Eyster; N Ghoshal; L I Binder; M P Vitek
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

10.  Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.

Authors:  Meaghan Morris; Akihiko Koyama; Eliezer Masliah; Lennart Mucke
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240
View more
  6 in total

Review 1.  Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.

Authors:  M A Artyukhova; Y Y Tyurina; C T Chu; T M Zharikova; H Bayır; V E Kagan; P S Timashev
Journal:  Free Radic Biol Med       Date:  2019-06-12       Impact factor: 7.376

Review 2.  Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.

Authors:  Paul J Derry; Muralidhar L Hegde; George R Jackson; Rakez Kayed; James M Tour; Ah-Lim Tsai; Thomas A Kent
Journal:  Prog Neurobiol       Date:  2019-10-08       Impact factor: 11.685

3.  Effects of Volatile Anaesthetics and Iron Dextran on Chronic Inflammation and Antioxidant Defense System in Rats.

Authors:  Dyana Odeh; Nada Oršolić; Emanuela Adrović; Lydia Gaćina; Petra Perić; Sahar Odeh; Vedran Balta; Nikola Lesar; Marina Kukolj
Journal:  Antioxidants (Basel)       Date:  2022-04-03

Review 4.  Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

Review 5.  Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders.

Authors:  Jing Li; Bowen Jia; Ying Cheng; Yiting Song; Qianqian Li; Chengliang Luo
Journal:  Oxid Med Cell Longev       Date:  2022-07-22       Impact factor: 7.310

Review 6.  Iron metabolism: current facts and future directions.

Authors:  Leida Tandara; Ilza Salamunic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.